미국의 리프로세스 의료기기 시장 규모, 점유율, 동향 분석 리포트 : 제품 유형별, 용도별, 부문별 예측(2024-2030년)

U.S. Reprocessed Medical Devices Market Growth & Trends:

The U.S. reprocessed medical devices market size is anticipated to reach USD 3.09 billion by 2030 and is anticipated to expand at a CAGR of 16.3% during the forecast period, according to a new report by Grand View Research, Inc. Many single-use devices are expensive and reprocessing them can help hospitals and healthcare facilities save a considerable amount of money. Reputable reprocess brands, such as Innovative Health and Stryker, adhere to strict quality control standards and regulatory requirements. Strict guidelines and standards are in place to ensure that reprocessed devices meet the same quality and safety requirements as new ones. This allows patients to receive high-quality care without the need to use new, potentially more expensive devices.

The increasing usage of these reprocessed medical devices over the newer ones every time leads to saving resources and cutting costs. For instance, as per the information published by the Association of Medical Device Reprocessors (AMDR), maximizing the use of reprocessed single-use medical devices can help hospitals in the U.S. to save approximately USD 2.28 billion annually.

To protect patient safety and preserve device efficacy, reprocessed medical devices need to go through stringent quality control and sterilizing procedures. The FDA oversees guaranteeing the efficacy, safety, and quality of medical devices, including ones that have undergone reprocessing. Reprocessed medical devices are classified as "single-use devices" since they have been sanitized, cleaned, and packed for further use. Under the Federal Food, Drug, and Cosmetic Act's Medical Device Amendments, the FDA oversees regulating these devices. Before putting their devices on the market, manufacturers of reprocessed devices have to get FDA clearance or approval and adhere to certain quality system requirements.

U.S. Reprocessed Medical Devices Market Report Highlights:

• The cardiovascular segment dominated the product segment with 56.5% share in 2023 and is expected to grow at the fastest CAGR over the forecast period. This high prevalence leads to a significant demand for medical devices used in cardiovascular treatments and diagnostics, which, in turn, creates demand for reprocessed medical devices
• The 3rd party reprocessing segment held the largest market share in 2023. Third-party reprocessing companies offer cost-effective solutions for reprocessing medical devices
• Hospitals dominated the end-use segment in 2023. Hospitals and healthcare facilities use reprocessed medical devices as they offer significant cost savings compared to purchasing new, single-use devices

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product type
  • 1.2.2. Type
  • 1.2.3. End-use
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product type outlook
  • 2.2.2. Type outlook
  • 2.2.3. End-use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Reprocessed Medical Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising incidence of diseases
    • 3.2.1.2. Technological advancements in healthcare
    • 3.2.1.3. Increasing emphasize on costs cutting
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent regulations & approvals
• 3.3. U.S. Reprocessed Medical Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Reprocessed Medical Devices Market: Product Type Estimates & Trend Analysis

• 4.1. Product Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. U.S. Reprocessed Medical Devices Market by Product Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
  • 4.4.1. Cardiovascular
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.2. Blood pressure cuffs
    • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.3. Positioning devices
    • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.4. Cardiac stabilization devices
    • 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.5. Diagnostic electrophysiology catheters
    • 4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.6. Deep vein thrombosis compression sleeves
    • 4.4.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.7. Electrophysiology cables
    • 4.4.1.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Laparoscopic
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.2. Harmonic scalpels
    • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.3. Endoscopic trocars
    • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Gastroenterology
    • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3.2. Biopsy forceps
    • 4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3.3. Others
    • 4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. General surgery
    • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4.2. Pressure bags
    • 4.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4.3. Balloon inflation devices
    • 4.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.5. Orthopedic
    • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Reprocessed Medical Devices Market: Type Estimates & Trend Analysis

• 5.1. Type Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. U.S. Reprocessed Medical Devices Market by Type Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
  • 5.4.1. 3rd party reprocessing
    • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. In-house reprocessing
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Reprocessed Medical Devices Market: End-use Estimates & Trend Analysis

• 6.1. End-use Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. U.S. Reprocessed Medical Devices Market by End-use Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
  • 6.4.1. Hospitals
    • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 6.4.2. Home healthcare
    • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Others
    • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company heat map analysis, 2023
• 7.4. Company Profiles
  • 7.4.1. Stryker
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Innovative Health
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. NEScientific, Inc.
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Medline Industries, Inc.
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Arjo
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Vanguard AG
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Cardinal Health
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. SureTek Medical
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Soma Tech Medical
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Johnson & Johnson Services, Inc.
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives